DKMA Update December 2018

Updated 23 January 2019

This newsletter features the following articles:

Further restrictions on the use of valproate
Risk of suicide to be reflected in the product information of contraceptive pills
Restricted use of antibiotics with quinolones and fluoroquinolones is advised
Stricter dose warning on the package of the arthritis and psoriasis medicine methotrexate
New biosimilar medicines for Humira

New growth plan boosted the Danish Medicines Agency’s ambition to join Europe’s best in class
Danish Medicines Agency part of inspection agreement between EU and the USA in 2018
Concerted campaign on safe online shopping received with great interest
Impurities found in several batches of blood pressure lowing medicine valsartan
A Danish registry study found a small increased risk of two forms of cancer with the use of hydrochlorothiazide
High turnout for theme events at the Danish Medicines Agency
Tonnes seized in global operation against illegal online sale of medicines
Danish Medicines Agency strengthened its international collaboration
Danish Medicines Agency represented at World Economic Forum
Top marks for the Danish Medicines Agency in European survey
Danish Medicines Agency launched a new concept for national scientific advice
Work began on a new register of medicinal products to benefit patient safety
Major efforts for safer prescription of blood thinning medicines
Better conditions for clinical trials in Denmark
European top post for Thomas Senderovitz
Medicinal cannabis pilot programme entered into force

Pharmaceutical companies must ensure people have access to package leaflets on www.indlaegsseddel.dk
Major European review of the subdivision of tablets